168 related articles for article (PubMed ID: 31344428)
1. Perturbed ovarian and uterine glucocorticoid receptor signaling accompanies the balanced regulation of mitochondrial function and NFκB-mediated inflammation under conditions of hyperandrogenism and insulin resistance.
Hu M; Zhang Y; Guo X; Jia W; Liu G; Zhang J; Cui P; Li J; Li W; Wu X; Ma H; Brännström M; Shao LR; Billig H
Life Sci; 2019 Sep; 232():116681. PubMed ID: 31344428
[TBL] [Abstract][Full Text] [Related]
2. Hyperandrogenism and insulin resistance induce gravid uterine defects in association with mitochondrial dysfunction and aberrant reactive oxygen species production.
Hu M; Zhang Y; Guo X; Jia W; Liu G; Zhang J; Li J; Cui P; Sferruzzi-Perri AN; Han Y; Wu X; Ma H; Brännström M; Shao LR; Billig H
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E794-E809. PubMed ID: 30860876
[TBL] [Abstract][Full Text] [Related]
3. Hyperandrogenism and insulin resistance modulate gravid uterine and placental ferroptosis in PCOS-like rats.
Zhang Y; Hu M; Jia W; Liu G; Zhang J; Wang B; Li J; Cui P; Li X; Lager S; Sferruzzi-Perri AN; Han Y; Liu S; Wu X; Brännström M; Shao LR; Billig H
J Endocrinol; 2020 Sep; 246(3):247-263. PubMed ID: 32590339
[TBL] [Abstract][Full Text] [Related]
4. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.
Zhang Y; Hu M; Yang F; Zhang Y; Ma S; Zhang D; Wang X; Sferruzzi-Perri AN; Wu X; Brännström M; Shao LR; Billig H
J Mol Med (Berl); 2021 Oct; 99(10):1427-1446. PubMed ID: 34180022
[TBL] [Abstract][Full Text] [Related]
5. Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome.
Zhang Y; Hu M; Meng F; Sun X; Xu H; Zhang J; Cui P; Morina N; Li X; Li W; Wu XK; Brännström M; Shao R; Billig H
EBioMedicine; 2017 Apr; 18():157-170. PubMed ID: 28336389
[TBL] [Abstract][Full Text] [Related]
6. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.
Zhang Y; Zhao W; Xu H; Hu M; Guo X; Jia W; Liu G; Li J; Cui P; Lager S; Sferruzzi-Perri AN; Li W; Wu XK; Han Y; Brännström M; Shao LR; Billig H
J Physiol; 2019 Aug; 597(15):3927-3950. PubMed ID: 31206177
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus.
Zhang Y; Sun X; Sun X; Meng F; Hu M; Li X; Li W; Wu XK; Brännström M; Shao R; Billig H
Sci Rep; 2016 Jul; 6():30679. PubMed ID: 27461373
[TBL] [Abstract][Full Text] [Related]
8. Use of Bao Gui capsule in treatment of a polycystic ovary syndrome rat model.
Lian Y; Zhao F; Wang W
Mol Med Rep; 2020 Mar; 21(3):1461-1470. PubMed ID: 32016479
[TBL] [Abstract][Full Text] [Related]
9. Suppression of uterine and placental ferroptosis by N-acetylcysteine in a rat model of polycystic ovary syndrome.
Hu M; Zhang Y; Ma S; Li J; Wang X; Liang M; Sferruzzi-Perri AN; Wu X; Ma H; Brännström M; Shao LR; Billig H
Mol Hum Reprod; 2021 Nov; 27(12):. PubMed ID: 34850077
[TBL] [Abstract][Full Text] [Related]
10. Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.
González F; Considine RV; Abdelhadi OA; Acton AJ
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2152-67. PubMed ID: 32140727
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
12. Selective impairment in glycogen synthase kinase-3 and mitogen-activated protein kinase phosphorylation: comparisons with the hyperandrogenic and the hyperinsulinemic rats.
Chen Y; Qiao J; Yan LY; Huang S; Zhao PL; Yan J
Fertil Steril; 2009 Oct; 92(4):1447-1455. PubMed ID: 19027112
[TBL] [Abstract][Full Text] [Related]
13. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
González F
Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
[TBL] [Abstract][Full Text] [Related]
14. Uterine progesterone signaling is a target for metformin therapy in PCOS-like rats.
Hu M; Zhang Y; Feng J; Xu X; Zhang J; Zhao W; Guo X; Li J; Vestin E; Cui P; Li X; Wu XK; Brännström M; Shao LR; Billig H
J Endocrinol; 2018 May; 237(2):123-137. PubMed ID: 29535146
[TBL] [Abstract][Full Text] [Related]
15. Uterine anomalies in cell proliferation, energy homeostasis and oxidative stress in PCOS hamsters, M. auratus: Therapeutic potentials of melatonin.
Hansda SR; Haldar C
Life Sci; 2021 Sep; 281():119755. PubMed ID: 34175318
[TBL] [Abstract][Full Text] [Related]
16. Defective Uterine Spiral Artery Remodeling and Placental Senescence in a Pregnant Rat Model of Polycystic Ovary Syndrome.
Hu M; Zhang Y; Zhang X; Zhang X; Huang X; Lu Y; Li Y; Brännström M; Sferruzzi-Perri AN; Shao LR; Billig H
Am J Pathol; 2023 Dec; 193(12):1916-1935. PubMed ID: 37689383
[TBL] [Abstract][Full Text] [Related]
17. Regulation of 11beta-hydroxysteroid dehydrogenase isoforms and glucocorticoid receptor gene expression in the rat uterus.
Ho CK; Tetsuka M; Hillier SG
J Endocrinol; 1999 Dec; 163(3):425-31. PubMed ID: 10588816
[TBL] [Abstract][Full Text] [Related]
18. Decreased brain and muscle ARNT-like protein 1 expression mediated the contribution of hyperandrogenism to insulin resistance in polycystic ovary syndrome.
Zhai J; Li S; Hu M; Di F; Liu J; Du Y
Reprod Biol Endocrinol; 2020 Apr; 18(1):32. PubMed ID: 32334629
[TBL] [Abstract][Full Text] [Related]
19. Electroacupuncture alleviates polycystic ovary syndrome-like symptoms through improving insulin resistance, mitochondrial dysfunction, and endoplasmic reticulum stress via enhancing autophagy in rats.
Peng Y; Guo L; Gu A; Shi B; Ren Y; Cong J; Yang X
Mol Med; 2020 Jul; 26(1):73. PubMed ID: 32698821
[TBL] [Abstract][Full Text] [Related]
20. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
